Melittin – the main component of bee venom: a promising therapeutic agent for neuroprotection through keap1/nrf2/ho-1 pathway activation

HIGHLIGHTS

• What: In this research, a second, more in depth, animal experiment was conducted (Figs 6, 7). The authors aimed to further investigate the mechanisms through which melittin exerts its effects. Mass spectra analysis was conducted to compare the commercial standard Keap1 with the extracted protein sample.
• Who: Cong Duc Nguyen from the This study was conducted in accordance with the Guide for the Care and Use of Laboratory Animals of the National Research Council (NRC, ) and was approved by the Committee of Animal Care and Experimentation of Dongshin University, Korea (DSU2021-0107)Mice were randomly . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.